The liver
- PMID: 29112863
- PMCID: PMC5897118
- DOI: 10.1016/j.cub.2017.09.019
The liver
Abstract
The liver is a critical hub for numerous physiological processes. These include macronutrient metabolism, blood volume regulation, immune system support, endocrine control of growth signaling pathways, lipid and cholesterol homeostasis, and the breakdown of xenobiotic compounds, including many current drugs. Processing, partitioning, and metabolism of macronutrients provide the energy needed to drive the aforementioned processes and are therefore among the liver's most critical functions. Moreover, the liver's capacities to store glucose in the form of glycogen, with feeding, and assemble glucose via the gluconeogenic pathway, in response to fasting, are critical. The liver oxidizes lipids, but can also package excess lipid for secretion to and storage in other tissues, such as adipose. Finally, the liver is a major handler of protein and amino acid metabolism as it is responsible for the majority of proteins secreted in the blood (whether based on mass or range of unique proteins), the processing of amino acids for energy, and disposal of nitrogenous waste from protein degradation in the form of urea metabolism. Over the course of evolution this array of hepatic functions has been consolidated in a single organ, the liver, which is conserved in all vertebrates. Developmentally, this organ arises as a result of a complex differentiation program that is initiated by exogenous signal gradients, cellular localization cues, and an intricate hierarchy of transcription factors. These processes that are fully developed in the mature liver are imperative for life. Liver failure from any number of sources (e.g. viral infection, overnutrition, or oncologic burden) is a global health problem. The goal of this primer is to concisely summarize hepatic functions with respect to macronutrient metabolism. Introducing concepts critical to liver development, organization, and physiology sets the stage for these functions and serves to orient the reader. It is important to emphasize that insight into hepatic pathologies and potential therapeutic avenues to treat these conditions requires an understanding of the development and physiology of specialized hepatic functions.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Figures


Similar articles
-
Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.J Endocrinol. 2017 Jul;234(1):R1-R21. doi: 10.1530/JOE-16-0513. Epub 2017 Apr 20. J Endocrinol. 2017. PMID: 28428362 Review.
-
Role of the liver in the control of glucose-lipid utilization and body weight.Curr Opin Clin Nutr Metab Care. 2003 Jul;6(4):449-55. doi: 10.1097/01.mco.0000078993.96795.16. Curr Opin Clin Nutr Metab Care. 2003. PMID: 12806220 Review.
-
Protein turnover, ureagenesis and gluconeogenesis.Int J Vitam Nutr Res. 2011 Mar;81(2-3):101-7. doi: 10.1024/0300-9831/a000064. Int J Vitam Nutr Res. 2011. PMID: 22139560 Review.
-
Lipid metabolism and nutrient partitioning strategies.Curr Drug Targets CNS Neurol Disord. 2004 Oct;3(5):411-30. doi: 10.2174/1568007043336932. Curr Drug Targets CNS Neurol Disord. 2004. PMID: 15544448 Review.
-
Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).Nutrients. 2017 Dec 29;10(1):29. doi: 10.3390/nu10010029. Nutrients. 2017. PMID: 29286303 Free PMC article. Review.
Cited by
-
Recent Advances in Mesenchymal Stem/Stromal Cell-Based Therapy for Alcohol-Associated Liver Disease and Non-alcoholic Fatty Liver Disease.Stem Cells Transl Med. 2024 Feb 14;13(2):107-115. doi: 10.1093/stcltm/szad082. Stem Cells Transl Med. 2024. PMID: 38016185 Free PMC article.
-
From liver fibrosis to hepatocarcinogenesis: Role of excessive liver H2O2 and targeting nanotherapeutics.Bioact Mater. 2022 Nov 12;23:187-205. doi: 10.1016/j.bioactmat.2022.11.001. eCollection 2023 May. Bioact Mater. 2022. PMID: 36406254 Free PMC article.
-
Prospect of Animal Models for Acute-on-chronic Liver Failure: A Mini-review.J Clin Transl Hepatol. 2022 Oct 28;10(5):995-1003. doi: 10.14218/JCTH.2022.00086. Epub 2022 Apr 28. J Clin Transl Hepatol. 2022. PMID: 36304511 Free PMC article. Review.
-
Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture.Stem Cell Res Ther. 2022 Mar 12;13(1):104. doi: 10.1186/s13287-022-02776-5. Stem Cell Res Ther. 2022. PMID: 35279203 Free PMC article.
-
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology.Nat Rev Gastroenterol Hepatol. 2020 Jan;17(1):40-52. doi: 10.1038/s41575-019-0212-0. Epub 2019 Oct 22. Nat Rev Gastroenterol Hepatol. 2020. PMID: 31641249 Review.
References
-
- Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, Canbay A. The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol. 2012;56:952–964. - PubMed
-
- Hijmans BS, Grefhorst A, Oosterveer MH, Groen AK. Zonation of glucose and fatty acid metabolism in the liver: mechanism and metabolic consequences. Biochimie. 2014;96:121–129. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources